What is YD Bio Ltd (YDES) stock price today?

YD Bio Ltd (YDES) currently trades at $5.11 per share. The stock has a market capitalization of $385.05M and a P/E ratio of —x.

Is YDES stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, YD Bio Ltd has a Smart Value Score of 22/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is YD Bio Ltd's revenue and earnings?

YD Bio Ltd has trailing twelve-month (TTM) revenue of $510360.00 with profit margins of -276.60%. Earnings per share (EPS) is $-0.02.

YDES

YD Bio Ltd

NASDAQ: YDES · HEALTHCARE · BIOTECHNOLOGY

$5.11

-1.53% today

Updated 2026-04-30

Market cap

$385.05M

P/E ratio

—

P/S ratio

754.46x

EPS (TTM)

$-0.02

Dividend yield

—

52W range

$5 – $25

Volume

0.0M

Market cap

$385.05M

P/E ratio

—

P/S ratio

754.46x

EPS (TTM)

$-0.02

Dividend yield

—

52W range

$5 – $25

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

6.3

Growth

5.0

Quality

C+

2.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$—

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 95.60% QoQ

Risks

- Thin margins at -276.60%

- Negative free cash flow $-298190.00

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	—	—	$350131.00	$510360.00	$510360.00
Net income	$8.70M	$3.79M	$13560.00	$-1.41M	$-2.21M
EPS	—	—	—	—	$-0.02
Free cash flow	$-688420.00	$-3.02M	$-55947.00	$-4.75M	$-298190.00
Profit margin	—	—	3.87%	-276.58%	-276.60%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
YDES	$385.05M	22	6.3	2.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

YD Bio Ltd trades at $5.11. Our Smart Value Score of 22/100 indicates the stock is weak. TTM revenue stands at $510360.00. with profit margins at -276.60%.

Frequently asked questions

What is YD Bio Ltd's stock price?

YD Bio Ltd (YDES) trades at $5.11.

Is YD Bio Ltd overvalued?

Smart Value Score 22/100 (Grade F, Strong Sell).

What is the price target of YD Bio Ltd (YDES)?

The analyst target price is $—, representing NaN% downside from the current price of $5.11.

What is YD Bio Ltd's revenue?

TTM revenue is $510360.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio754.46x

ROE-42.70%

Beta0.22

50D MA$7.16

200D MA$11.74

Shares out0.07B

Float0.00B

Short ratio—

Avg volume0.0M

Performance

1 week-5.97%

1 month-23.56%

3 months-52.41%

YTD-55.41%

1 year—

3 years—

5 years—

Compare

YDES vs LLY →YDES vs JNJ →YDES vs ABBV →Stock screener →